Subscribe to RSS - ResMed

ResMed

ResMed advances patent case

 - 
11/20/2013

SAN DIEGO – ResMed has won preliminary injunctions in Germany against two medical device manufacturers for alleged patent infringements.

ResMed, Invacare declare quarterly dividends

 - 
11/18/2013

ELYRIA, Ohio, and SAN DIEGO – The board of directors of Incavare has announced a cash dividend of $0.0125 per share of common shares and $0.011364 per share of Class B common shares, to be paid Jan. 13, 2014, to shareholders of record on Jan. 3, 2014.

ResMed acknowledges ‘temporary distraction’

 - 
10/25/2013

SAN DIEGO – Round 2 of competitive bidding has tapped the brakes on ResMed’s growth, officials acknowledged during a conference call Oct. 24 to discuss the company’s first quarter 2014 earnings.

ResMed reports increased income, revenue

 - 
10/25/2013

SAN DIEGO – ResMed reported net income of $80.9 million for the quarter ended Sept. 30 compared to $71.3 million for the same period last year, a 14% increase.

Brightree, ResMed agreement streamlines ordering

 - 
10/02/2013

ATLANTA and SAN DIEGO – Brightree and ResMed have signed an electronic data exchange agreement to help joint customers streamline their business processes.

In brief: CMS delays F2F rule again, Golden endorses Reverie

 - 
09/13/2013

BALTIMORE – CMS had no choice but to delay—for the second time—enforcement of its face-to-face rule until sometime in 2014, say industry stakeholders. “We just haven’t seen any further education,*” said Kim Brummett, senior director of regulatory affairs for AAHomecare.

Compliant patient, efficient provider

 - 
09/11/2013

In a move they believe will make patients more compliant and HME providers more efficient, two of the largest manufacturers of CPAP devices have rolled out mobile and web-based sleep therapy tools.

ResMed director sells $1.2m in company stock

 - 
09/10/2013

SAN DIEGO – Peter Farrell, ResMed director, sold 25,000 shares of stock on Sept. 5.

Patients in place for ResMed sleep apnea study

 - 
09/03/2013

AMSTERDAM – More than 1,300 patients are signed up for a large study examining the outcomes of heart-failure patients using ResMed’s PaceWave to treat central sleep apnea. ResMed announced Sept.

Manufacturers reassess terms

 - 
08/30/2013

YARMOUTH, Maine – With three high-profile HME providers now moving through the bankruptcy process, should it come as a surprise that manufacturers are trying to protect themselves by tightening their payment terms?

Pages